1. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994; 18:1-12.
2. Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10:509–15.
3. Hamida K, Fahmida M, Shafiullah AZM. Farhana M. Prevalence and comparative likelihood of urinary tract infection among female out patients in BSMMU. Bangladesh J. Zool 2012; 40(2): 231-239.
4. Rahn DD. Urinary tract infections: contemporary management. Urol Nurs 2008; 28:333–41.
5. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113:5–11S.
6. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468–74.
7. Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 1999; 17: 415–20.
8. Jackson SL, Boyko IJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause. Am J Med 2004; 117:903.
9. Rosen DA, Hooten TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLOS Med 2007; 4: 329.
10. Mohsin R, Siddiqui KM. Recurrent urinary tract infections in females. J Pak Med Assoc 2010; 60: 55– 9.
11. Foster RT Sr. Uncomplicated urinary tract infections in women. Obstet Gynecol Clin North Am 2008; 35:235–48.
12. Scholes D, Hooton TM, Roberts PL, Stapleton AE,Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182:1177–82.
13. Epp A, Larochelle A, Lovatsis D, Walter JE, Easton W, Farrell SA, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can 2010; 32: 1082–101.
14. Franco VMA. Recurrent urinary tract infections. Best Pract & Research Clinical Obstet Gynecol 2005;19:861–73.
15. Anukam KC, Osazuwa EO, Ahonkhai I, Reid G. 16S rRNA gene sequence and phylogenetic tree of Lactobacillus species from the vagina of healthy Nigerian women. Afr J Biotechnol 2005;4:1222–27.
16. Cribby S, Taylor M, Reid G. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis 2008;2008:256–490.
17. Burton JP, Reid G. Evaluation of the bacterial vaginal flora of twenty postmenopausal women by direct (Nugent Score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J Infect Dis 2002; 186:1777–80.
18. Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999; 180:1950–6.
19. Yoshimura T, Okamura H. Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas 2001; 39:253–7.
20. Devillard E, Burton JP, Hammond JA, Lam D, Reid G. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis. Eur J Obstet Gynecol Reproductive Biol 2004; 117:76–81.
21. Galask RP. Vaginal colonization by bacteria and yeast. Am J Obstet Gynecol 1988; 158:993–5.
22. Burton JP, Cadieux P, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003; 69:97–101.
23. Vásquez A, Jakobsson T, Ahrné S, Forsum U, Molin G. Vaginal Lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002; 40:2746–9.
24. Chan RCY, Bruce AW, Reid G. “Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion,” The Journal of Urology 1984;131(3):596–601.
25. Ikeh KI. Methicillin-resistant Staphylococcus aureus (MRSA) at Jos University Teaching Hospital. Afr J Clin Exp Microbiol 2003;4:52-5.
26. Rayes N, Seehofer D, Muller AR, Hansen S, Bengmark S, Neuhaus P. Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery. Z Gastroenterol 2002;40:869–76.
27. Lata J, Jurankova J, Pribramska V, Fric P, Senkyrik M, Dite P, et al. Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endotoxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis. Vnitr Lek 2006; 52:215–9.
28. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ 2002; 32435:1361.
29. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004 CD003048.
30. Antonio B, Adriana B F, Angela A and Eviralda M. Helicobacter pylori Infection Is Associated with Development of Irritable Bowel Syndrome Journal of Exploratory Research in Pharmacology 2016 vol. 1
31. Bengmark S. Gut microbial ecology in critical illness: is there a role for prebiotics, probiotics, and synbiotics? Curr Opin Crit Care 2002; 8:145–151.
32. Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35(2):131-134.
33. Stamm WE, Hooton TM, Stapleton AE, Deshaw N. Intravaginal LACTIN-V for prevention of recurrent urinary tract infection.. Available from: http://www.clinicaltrials.gov.
34. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot Study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents 2006;28:S30-4.
35. Darouiche RO, Thornby JI, Cerra-Stewart C, Donovan WH, Hull RA. Bacterial interference for prevention of urinary tract infection: A prospective, randomized, placebo-controlled, double-blind pilot trial. Clin Infect Dis 2005;41:1531-4.
36. Reid G, Bruce AW, Taylor M. Influence of 3-day antimicrobial therapy and Lactobacillus suppositories on recurrence of urinary tract infection. Clin. Ther 1992;14:11-16.
37. Reid G, Bruce AW. Could probiotics be an option for treating and preventing urogenital infections? Medscope Womens Health. 2001;6:9.
38. Mari AJ, Beerepoot, Reit GT, Nys S, Wal WMV, Corianne AJM, Borgie D, Reijke TMD, Prins JM, Koeijers J, Verbon A, Stobberingh E, Suzanne E, Gerllings. Lactobacilli vs Antibiotics to prevent Urinary Tract Infections: A Randomized, double-blind, noninferiority, Trial in Postmenopausal Women. Arch. Intern Med. 2012;172(9):704-712.
39. D. Borchert,1 L. Sheridan,2 A. Papatsoris,1 Z. Faruquz,1 J. M. Barua,3 I. Junaid,1 Y. Pati,1,4 F. Chinegwundoh,1,5 and N. Buchholz1,5Indian journal of Urology april-june 2008
40.Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003;17:227-41. [CrossRef]
41.Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000;151:1194-205. [CrossRef]
42. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182:1177–82. [PubMed: 10979915]
43. Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE. Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis. 2000;181:595–601. [PubMed: 10669343]
44. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152–6. [PubMed: 10619744]
45. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis. 2001;183(Suppl 1):S74–6. [PubMed: 11171020]
46. Krieger JN. Complications and treatment of urinary tract infections during pregnancy. Urol Clin NorthAm. 1986;13:685–93. [PubMed: 3535210]
47. Giesen LG, Cousins G, Dimitrov BD, van de Laar FA, Fahey T. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract 2010;11:78.
48.Knottnerus B, Geerlings E, Moll van Charante E, ter Riet G. Towards a simple diagnostic index for acute uncomplicated urinary tract infections. Ann Fam Med 2013;11:442e50.
49.Verheij RA, Van Dijk CE, Abrahamse H, Davids R, Vanden Hoogen H, Braspenning J, et al. Landelijk informatienetwerk Huisartsenzorg. Feiten en cijfers over huisartsenzorg in Nederland. Utrecht/Nijmegen: NIVEL/IQhealthcare; 2009.
50. Bova JG, Potter JL, Arevalos E, Hopens T, Goldstein HM, Radwin HM. Renal and perirenal infection: to he role of computerized tomography. J Urol.1985;133:375–8. [PubMed]
51. Nicolle LE. Resistant pathogens in urinary tract infections. J Am GeriatrSoc 2002;50:S230-5
52.B H N Yasmeen et al.Prevalence of urinary tract infection, its causative agents and antibiotic sensitivity pattern : A study in Northern International Medical College Hospital, July 2015, vol 7 Singh MM, Devi R, Garg S, Mehra M. Effectiveness of syndromic approach in management of reproductive tract infections in women. Indian J Med Sci.2001;55(4):209–214. [PubMed]
53. Bashar MA, Ahmed MF, Rahman SR, Gomes DJ. Distribution and Resistance Trends of Escherichia coli from Urinary Tract Infections Isolated in Dhaka City. Ban J Med Sci. 2009;15(2):93–98.
54. Saber MH, Barai L, J Haq A, Jilani MSA, Begum MJ. The Pattern of Organism Causing Urinary Tract Infection in Diabetic and Non Diabetic Patients in Bangladesh. Bangladesh J Med Microbiol. 2010;04(01):6–8.
55. Ikeh KI. Methicillin-resistant Staphylococcus aureus (MRSA) at Jos University Teaching Hospital. Afr J ClinExpMicrobiol 2003;4:52-5.
56. Bhowmick B K,Rashid H. Prevalence and antibiotic susceptibility of E coli Isolated fromUrinary tract infections (UTI) in Bangladesh. Pak.J.Biol.Sci. 2004,7 (5):717-720
57. Blomberg B, Olsen BE, Hinderaker SG, Langeland N, Gasheka P, Jureen R, Kvale G, Midtvedt T: Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: implications for republic health. Scandinavian Journal of Infectious Diseases 2005, 37(4):262-8.
58.Haider G, Zehra N, Munir AA, Haider A: Risk factors of urinary tract infection in pregnancy. J Pak Med Assoc 2010, 60(3):213-6.
59.Mathai E, Thomas RJ, Chandy S, Mathai M, Bergstrom S: Antimicrobials for the treatment of urinary tract infection in pregnancy: practices in southern India. Pharmacoepidemiol Drug Saf 2004, 13(9):645-52.
60. Alexander J. Kallen, MD; H. Gilbert Welch, MD, MPH; Brenda E. Sirovich, MD, MS. Current Antibiotic Therapy for Isolated Urinary Tract Infections in Women.https://jamanetwork.com/ on 04/27/2022.
61.Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001;32:37-41. [CrossRef]
62. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52. [CrossRef]
63. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35:131-4. [CrossRef]
64. Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 2004;38:S107-10.
65. Zuccotti GV, Meneghin F, Raimondi C, Dilillo D, Agostoni C, Riva E, et al. Probiotics in clinical practise: an overview. J Int Med Res 2008;36(Suppl 1):1A-53A.
66. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001;32:37–41. [PubMed: 11750220]
67. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35:131–4.[PubMed: 12628548]